Nanotechnology and drug delivery

Biomedical Nanostructures

Volumn , Issue , 2007, Pages 93-113

  Yu, Xiaojun ^a   Valmikinathan, Chandra M ^a   Rogers, Amanda ^a   Wang, Junping ^a  

^a STEVENS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Intracellular drug delivery; Nanotechnology based drug delivery devices; Temperature responsive polymer

Indexed keywords

EID: 79960912106     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470185834.ch5     Document Type: Chapter

References (79)

1. Roco M. Nanotechnology: convergence with modern biology and medicine. Cur Opin Biotechnol 2003;14:337-346.
2. National nanotechnology initiatives Advisory on nanobiotechnology. National Science Foundation (NNI); 2003; p. 1-108.
3. Gourley P. Brief overview of biomicronano technologies. Biotechnol Prog 2005;21 (1):2-10.
4. Sahoo AK and Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discov Today 2003;24:1112-1120.
5. Sinkula M and Paul R. Investing in nanobiotechnology. Nat Biotechnol 2003;10: 1144-1147.
6. Koo OM, Rubinstein I, Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomed Nanotechnol Biol Med 2005;1: 193-212.
7. Loo C, Lowery A, Halas N, West J. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nanolett 2005;5(4):709-711.
8. Trehin R, et al. Fluorescent nanoparticle uptake for brain tumor visualization. Neoplasia 2006;8(4):302-311.
9. Cyrus T, et al. Three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles. J Cardiovasc Magn Reson 2006;8(3):535-541.
10. Zharov V, Mercer K, Galitovskaya E, Smeltzer M. Photothermal nanotherapeutics and nanodiagnostics for selective killing of bacteria targeted with gold nanoparticles. Biophys J 2006;90(2):619-627.
11. Sullivan D and Ferrari M. Nanotechnology, tumor imaging-seizing an opportunity. Mol Imaging 2004;3(4):364-369.
12. Bertin P, et al. Multifunctional polymeric nanoparticles from diverse bioactive agents. J Am Chem Soc 2006;128(13):4168-9.
13. Grodzinski P, Silver M, Molnar L. Nanotechnology for cancer diagnostics: promises and challenges. Expert Rev Mol Diagn 2006;6(3):307-318.
14. Orive G and PedrazJL. Drug delivery in biotechnology: present and future. Curr Opin Biotechnol 2003;14:659-664.
15. Carino G and Edith M. Oral-insulin delivery. Adv Drug Deliv Rev 1999;35: 249-257.
16. McAllister D and PrausnitzM. Microfabricated microneedles for gene and drug delivery. Annu Rev Biomed Eng 2000;2:289-313.
17. Khademhosseini A and Langer R. Nanobiotechnology for tissue engineering and drug delivery, Chemical Engineering Program, 2006;102:38-42.
18. Otilia K and Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine 2005;1:193-212.
19. Visser CC, et al. Nanoparticles bearing polyethylene glycol-coupled transferrin as gene carriers: preparation and in vitro evaluation. Int J Pharm 2005;25:299-305.
20. Leamon CP and Reddy JA. Folate-targeted chemotherapy. Adv Drug Deliv Rev 2004;80:1127-1141.
21. AlvarezV and SanzL. Antibody engineering: facing new challenges in cancer therapy. Acta Pharmacol Sin 2005;6:641-648.
22. Majeti RK. Nano and micro particles as controlled drug delivery devices. J Pharm Pharm Sci 2000;3(2):234-258.
23. Saltzman W and Baldwin S. Materials for protein delivery in tissue engineering. Adv Drug Deliv Rev 1998;(33):71-86.
24. Owens DE and III Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 2006;307:93-102.
25. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 2001;47: 113-131.
26. Teixeira M, Alonson MJ, Pinto MMM, Barbosa CM. Development and characterization of PLGA nanospheres and nanocapsules containing xanthaone and 3-methoxyanthone. Eur J Pharm Biopharm 2005;59:491-500.
27. Otsuka H, Nagasaki Y, Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev 2003;44:402-419.
28. Kearsey J. Strategies for intracellular drug delivery. The Drug Delivery Companies Report, 2004. p. 43-46.
29. Hoffman A. Design of smart polymers that can direct intracellular drug delivery. Polym Adv Technol 2002;13:992-999.
30. Torchilin V. Recent approaches to intracellular delivery of drugs and dNA and organelle targeting. Annu Rev Biomed Eng 2006;8:343-375.
31. Nishiyama N, Bae Y, Miyata K, Fukuchima S. Smart polymeric micelles for gene and drug delivery. Drug Discov Today: Technol 2005;2:21-26.
32. Shi G, Gui W, Stephenson SM, Lee RJ. Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations. J Control Rel 2002;80:309-319.
33. Liang L, Ping J, Ming C, Guoliang Z, Fengbao Z. 5-Fluorouracil-loaded selfassmebled pH-sensitive nanoparticles as novel drug carrier for treatment of malignant tumors. Chin J Chem Eng 2006;14:377-382.
34. Lo CL, Lin KM, Hsiue GH. Preparation and characterization of intelligent core-shell nanoparticles based on poly(D,l-lactide)-g-poly(N-isopropyl acrylamideco-methacrylic acid). J Control Rel 2005;104:477-488.
35. Meissner Y, Pellequer Y, Lamprecht A. Nanoparticles in inflammatory bowel disease: particle targeting versus pH-sensitive delivery. Int J Pharma 2006;316: 138-143.
36. Chaw CS, et al. Thermally responsive core-shell nanoparticles self-assembled from cholesteryl end-capped and grafted polyacrylamides: drug incorporation and in vitro release. Biomaterials 2004;25:4297-4308.
37. Bae Y, Fukushima S, Harada A. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. Angew Chem Int Ed 2003;42:4640-4643.
38. Kataoka K, et al. Doxorubicin-loaded poly(ethylene glycol)-poly(ß-benzyl-Laspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J Control Rel 2000;64:143-153.
39. Gil ES and Hudson SM. Stimuli-responsive polymers and their bioconjugates. Prog Polym Sci 2004;29:1173-1222.
40. Cammas S, et al. Thermo-responsive polymer nanoparticles with a core-shell micelle structure as site-specific drug carriers. J Control Rel 1997;48:157-164.
41. Berg K, et al. Photochemical internalization: a novel technology for delivery of macromolecules into cytosol, Cancer Res, 1999;59(6):1180-1183.
42. Engesaeter B, et al. PCI-enhanced adenoviral transduction employs the known uptake mechanism of adenoviral particles. Can Gen Ther 2005;12(5):439-448.
43. Berg K, Selbo P, Prasmickaite L, Hogset A. Photochemical drug and gene delivery. Curr Opin Mol 2004;6(3):279-287.
44. Berg K, Dietze A, Kaalhus O, Hogset A. Site-specific drug delivery by photochemical internalization enhances the antitumor effect of bleomycin. Clin Canc Res 2005;11(23):8476-85.
45. Derycke A and De Witte P. Liposomes for photodynamic therapy. Adv Drug Deliv Rev 2004;56(1):17-30.
46. Chen B, Pogue B, Hasan T. Liposomal delivery of photosensitising agents. Expert Opin Drug Deliv 2005;2(3):477-487.
47. Konan Y, Gurny R, Allemann E. State of the art in the delivery of photosensitizers for photodynamic therapy. J Photochem Photobiol B 2002;66(2):89-106.
48. Ideta R, et al. Nanotechnology-based photodynamic therapy for neovascular disease using a supramolecular nanocarrier loaded with a dendritic photosensitizer. Nanoletters 2005;5(12):2426-31.
49. Leach J. Thesis on magnetic targeted drug delivery. Virginia Polytechnic; 2003. p 83.
50. Hofer K. Hyperthermia and cancer, In: Fourth International Conference on Scientific and Clinical Applications of Magnetic Carriers. 2002;12:78-80.
51. Ng K-Y and Matsunaga T. Ultrasound Mediated Drug Delivery. In: Wang B, editor. Drug Delivery: Principles and Application.Wiley; 2005.
52. Rapaport N. Cancer therapy by micellar-encapsulated drug and ultrasound. Int J Pharm 2004;277:155-162.
53. Farokhzad OC, et al. Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Can Res 2004;64:7668-7672.
54. Pestourie C, Tavitian B, Duconge F. Aptamers against extracellular targets for in vivo applications. Biochimie 2005;87:921-930.
55. Farokhzad OC, et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Nat Acad Sci USA 2006;103:6315-6320.
56. Russell-Janes GJ, Veitch H, Arthur L. Lectin-mediated transport of nanoparticles across Caco-2 and OK cells. Int J Pharm 1999;190:165-174.
57. Li Y, Ogris M, Wagner E, Pelisek J, Rueffer M. Nanoparticles bearing polyethylene glycol-coupled transferrin as gene carriers: preparation and in vitro evaluation. Int J Pharm 2003;229:93-101.
58. Nah JW, Yu L, Han So, Ahn CH, Kim SW. Artery wall binding peptidepoly( ethylele glycol)-grafter- poly(L-lysine)-based gene delivery to artery wall cells. J Control Rel 2002;78:273-284.
59. Malavasi F and Funaro A. Monoclonal antibodies for therapy of human cancers. Biotechnol Adv 2000;18:385-401.
60. Lee R and Lawrence L. Bispecific antibodies: targeting cancer and much more. Exp Hematol 2006;34:1-6.
61. Rong-Lu Z and Kopecek J. Design of novel bioconjugates for targeted drug delivery. J Control Release 2001;78:165-173.
62. Peppas NA and Kavimandan NJ. Nanoscale analysis of protein and peptide absorption: insulin absorption using complexation and pH-sensitive hydrogels as delivery vehicles. Eur J Pharm Sci 2006 (1):83-87.
63. Mitra A, et al. Targeting tumor angiogenic vasculature using polymer-RGD conjugates. J Control Release 2005;102:191-201.
64. Dharap SS, et al. Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides. J Control Release 2003;91:61-73.
65. Gillies ER and Frechet JMJ. Dendrimers and dendritic polymers in drug delivery. Drug Disc Today 2005;10:35.
66. Patri AK, Majoros IJ, Baker JR. Dendritic polymer macromolecular carriers for drug delivery. Curr Opin Chem Biol 2002;6:466-471.
67. Bianco A, Kostarelos K, Prato M. Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol 2005;9:674-679.
68. Pantarotto D, et al. Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chem Biol 2003;10:961-966.
69. Klumpp C, Kostarelos K, Prato M, Bianco A. Functionalized carbon nanotubes as emerging nanovectors for the delivery of therapeutics. Biochim Biophys Acta 2006;1758:404-412.
70. Wu W, et al. Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes. Angew Chem Int Ed 2005;44:6358-6362.
71. Penn SG, He L, Natan MJ. Nanoparticles for bioanalysis. Curr Opin Chem Biol 2003;7:609-615.
72. Ben N. Natural, bioceramics: from coral to bone and beyond. Curr Opin Solid State Mater Sci 2003;7:283-288.
73. Yeh JI, Zimmt MB, Zimmerman AL. Nanowiring of a redox enzyme by metallized peptides. Biosens Bioelectron 2005;21:973-978.
74. Riess G. Micellization of block copolymers. Prog Polym Sci 2003;12:87-91.
75. Chan W. Bionanotechnology progress and advances. Am Soc Blood Marrow Transpl 2006;12:87-91.
76. Shinkai M, et al. Intracellular hyperthermia for cancer using magnetite cationic liposomes. J Magn Magn Mater 1999;194:176-184.
77. Myer L, et al. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv 2004;11:169-183.
78. Yang YC WC, Hwu YK, Je JH. Synchrotron X-ray synthesis of colloidal gold particles for drug delivery. Mater Chem Phys 2006.
79. Rauschmann MA, et al. Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. Biomaterials 2005;26:2677-2684.